China Medical System Holdings Limited
CHSYF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $4,002 | $3,858 | $3,611 | $3,403 |
| % Growth | 3.7% | 6.8% | 6.1% | – |
| Cost of Goods Sold | $1,110 | $1,132 | $915 | $933 |
| Gross Profit | $2,892 | $2,726 | $2,697 | $2,470 |
| % Margin | 72.3% | 70.7% | 74.7% | 72.6% |
| R&D Expenses | $202 | $224 | $106 | $119 |
| G&A Expenses | $431 | $419 | $362 | $339 |
| SG&A Expenses | $1,855 | $1,680 | $1,762 | $1,510 |
| Sales & Mktg Exp. | $1,424 | $1,261 | $1,400 | $1,172 |
| Other Operating Expenses | $0 | -$82 | $0 | $0 |
| Operating Expenses | $2,058 | $1,822 | $1,868 | $1,630 |
| Operating Income | $834 | $904 | $829 | $840 |
| % Margin | 20.8% | 23.4% | 23% | 24.7% |
| Other Income/Exp. Net | $310 | -$30 | $307 | -$249 |
| Pre-Tax Income | $1,144 | $874 | $1,136 | $591 |
| Tax Expense | $213 | $164 | $233 | $123 |
| Net Income | $941 | $709 | $910 | $480 |
| % Margin | 23.5% | 18.4% | 25.2% | 14.1% |
| EPS | 0.39 | 0.29 | 0.37 | 0.2 |
| % Growth | 34.5% | -21.6% | 85% | – |
| EPS Diluted | 0.39 | 0.29 | 0.37 | 0.2 |
| Weighted Avg Shares Out | 2,419 | 2,427 | 2,438 | 2,452 |
| Weighted Avg Shares Out Dil | 2,419 | 2,427 | 2,438 | 2,452 |
| Supplemental Information | – | – | – | – |
| Interest Income | $37 | $126 | $0 | $87 |
| Interest Expense | $0 | $39 | $0 | $0 |
| Depreciation & Amortization | $105 | $145 | $114 | $106 |
| EBITDA | $939 | $1,365 | $943 | $946 |
| % Margin | 23.5% | 35.4% | 26.1% | 27.8% |